CompaniesOcata Therapeutics

Ocata Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

By Phase

PHASE1/PHASE2: 1

By Status

WITHDRAWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2012

2013

2014

2015

2016

2017

Today

Hover over trial bars to see details

Recent Trials

NCT02122159Collaborator

Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

PHASE1/PHASE2Withdrawn

Started: Mar 31, 2013 · Completed: Jul 31, 2016

Funding History (20)

8-K

Feb 10, 2016

8-K

Dec 18, 2015

8-K

Nov 10, 2015

8-K

Aug 31, 2015

8-K

Aug 19, 2015

8-K

Aug 6, 2015

8-K

Jul 24, 2015

8-K

Jun 17, 2015

DEFA14A

Jun 11, 2015

DEF 14A

Jun 11, 2015

Related Companies

Astellas

acquired